Associate Director, Medicinal Chemistry Discovery and Stakeholder Management
Dr Tifelle Reisinger is a medicinal chemist with drug discovery experience in the pharmaceutical industry and contract research organisations (CRO) in France, UK and Australia.
Tifelle completed her Ph.D. in organic chemistry at The University of Paris and the Institute of Chemistry of Natural Substances (ICSN) in France and undertook further post-doctoral studies at the University of Cambridge in the UK before transitioning to industry.
Tifelle worked with drug discovery CROs in the UK, Concept Life Sciences in Sandwich and Domainex in Cambridge, before relocating to Melbourne in 2017 as Head of Business Development, Asia Pacific for Domainex. With a strong client-focus and business acumen, she generated and managed a portfolio of clients including biotech companies, venture capitals and leading academic research institutes across Australia.
Tifelle joined BioCurate in 2019 and as a Venture Partner, she managed the MRFF-BTB (Biomedical Translation Bridge) Program delivered by MTPConnect, in partnership with UniQuest and MDPP. With her medicinal chemistry expertise, she evaluates projects for investment at BioCurate, as well as managing and supporting drug discovery campaigns for small molecule programs from hit identification through to candidate nomination in the fields of oncology, cardiovascular diseases and neurosciences.